# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-066234
Filing Date
2023-08-11
Accepted
2023-08-11 16:06:34
Documents
75
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0623_jasperthera.htm iXBRL | 10-Q | 848619
2 | AMENDMENT NO. 2 TO THE EXCLUSIVE LICENSE AGREEMENT, DATED JULY 27, 2023, BETWEEN | f10q0623ex10-2_jasperthera.htm | EX-10.2 | 13702
3 | CERTIFICATION | f10q0623ex31-1_jasperthera.htm | EX-31.1 | 10202
4 | CERTIFICATION | f10q0623ex31-2_jasperthera.htm | EX-31.2 | 9843
5 | CERTIFICATION | f10q0623ex32-1_jasperthera.htm | EX-32.1 | 5125
| Complete submission text file | 0001213900-23-066234.txt |  | 5201784

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | jspr-20230630.xsd | EX-101.SCH | 71085
7 | XBRL CALCULATION FILE | jspr-20230630_cal.xml | EX-101.CAL | 36291
8 | XBRL DEFINITION FILE | jspr-20230630_def.xml | EX-101.DEF | 278746
9 | XBRL LABEL FILE | jspr-20230630_lab.xml | EX-101.LAB | 551857
10 | XBRL PRESENTATION FILE | jspr-20230630_pre.xml | EX-101.PRE | 298682
69 | EXTRACTED XBRL INSTANCE DOCUMENT | f10q0623_jasperthera_htm.xml | XML | 554708

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39138 | Film No.: 231164067
SIC: 2836 Biological Products, (No Diagnostic Substances)